Riancho-Zarrabeitia, L., Taboada, V. M., Rua-Figueroa, I., Sánchez-Alonso, F., Galindo-Izquierdo, M., Ovalles, J., Olivé, A., Fernandez-Nebro, A., Calvo, J., Menor-Almagro, R., Muriel, E. T., Isacelaya, E. U., Boteanu, A., Andres, M., González, M. F., Soler, G. S., Lucea, E. R., Barceló, M. I., Castellví, I., Galisteo, C., Vila, V. Q., Raya, E., Narváez, J., Expósito, L., A Hernandez Beriain, J., Horcada, L., & Pego-Reigosa, J. M. (n.d.). oP0124 DO ALL ANTIPHOSPHOLIPID ANTIBODIES CONFER THE SAME RISK FOR MAJOR ORGAN INVOLVEMENT IN SLE PATIENTS?. Annals of the rheumatic diseases, 78, 136–137. http://access.bl.uk/ark:/81055/vdc_100144732214.0x00005a